MSN Labs enters into licensing agreement with Eli Lilly to launch COVID-19 drug in India
MSN Labs (MSN) has announced that it has entered into a royalty-free, non-exclusive, and voluntary licence agreement with US-based Eli Lilly and Company to manufacture and market Baricitinib drug for…